Journal: Carbohydrate research
Article Title: Utilization of bench-stable and readily available nickel(II) triflate for access to 1,2-cis-2-aminoglycosides.
PMID/MRN: 27816838
Publication Date: 2016-Nov-29
Abstract:
The utilization of substoichiometric amounts of commercially available nickel(II) triflate as an activator in the reagent-controlled glycosylation reaction for the stereoselective construction of biologically relevant targets containing 1,2-cis-2-amino glycosidic linkages is reported. This straightforward and accessible methodology is mild, operationally simple and safe through catalytic activation by readily available Ni(OTf) 2 in comparison to systems employing our previously in-house prepared Ni(4-F-PhCN) 4 (OTf) 2 . We anticipate that the bench-stable and inexpensive Ni(OTf) 2 , coupled with little to no extra laboratory training to set up the glycosylation reaction and no requirement of specialized equipment, should make this methodology be readily adopted by non-carbohydrate specialists. This report further highlights the efficacy of Ni(OTf) 2 to prepare several bioactive motifs, such as blood type A-type V and VI antigens, heparin sulfate disaccharide repeating unit, aminooxy glycosides, and ?-GalNAc-Serine conjugate, which cannot be achieved in high yield and ?-selectivity utilizing in-house prepared Ni(4-F-PhCN) 4 (OTf) 2 catalyst. The newly-developed protocol eliminates the need for the synthesis of Ni(4-F-PhCN) 4 (OTf) 2 and is scalable and reproducible. Furthermore, computational simulations in combination with 1 H NMR studies analyzed the effects of various solvents on the intramolecular hydrogen bonding network of tumor-associated mucin Fmoc-protected GalNAc-threonine amino acid antigen derivative, verifying discrepancies found that were previously unreported.
Copyright © 2016 Elsevier Ltd. All rights reserved.